Pharma groups to tackle greenhouse gases from asthma inhalers
GSK and AstraZeneca plan final trials to upgrade propellants that cause much of the sector’s carbon footprint
GSK and AstraZeneca plan final trials to upgrade propellants that cause much of the sector’s carbon footprint